← FDA Drug Approvals (Drugs@FDA)
MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANI PHARMS · Approved 2023-12-15
Drug application
- FDA Application #
ANDA208237- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
- Generic name
- MEMANTINE AND DONEPEZIL HYDROCHLORIDES
- Active ingredients
- DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ANI PHARMS
- Manufacturer
- ANI Pharmaceuticals, Inc.
- First approval
- 2023-12-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown